HIVE CLX Solution

About Honeycomb Biotechnologies

Honeycomb Biotechnologies is a private, pre-revenue platform company founded in 2017 and based in Cambridge, Massachusetts. The company's core innovation is the HIVE™ platform, which aims to simplify and improve single-cell analysis by enabling gentle capture, ambient storage, and sequencing of cells from any location, reducing data variability. While initially demonstrated in neuroscience applications like brain organoid research, the platform is positioned as a flexible tool with broad applicability across research and drug discovery. Honeycomb's business model likely involves selling instruments, consumables, and associated services to academic, biopharma, and clinical research customers.

Therapeutic Areas

Other Research Tool for Single-Cell Analysis Drugs